FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., indicating an updated approval under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)